articl
describ
patholog
studi
fatal
sever
acut
respiratori
syndrom
sar
man
outbreak
sar
taiwan
eight
day
onset
symptom
visit
municip
hospit
later
identifi
epicent
larg
outbreak
sar
admiss
nation
taiwan
univers
hospit
taipei
patient
experienc
chest
tight
progress
dyspnea
lowgrad
fever
condit
rapidli
deterior
increas
respiratori
difficulti
die
day
admiss
promin
histopatholog
find
diffus
alveolar
damag
lung
immunohistochem
situ
hybrid
assay
demonstr
evid
sarsassoci
coronaviru
sarscov
infect
variou
respiratori
epitheli
cell
predominantli
type
ii
pneumocyt
alveolar
macrophag
lung
electron
microscop
examin
also
reveal
coronaviru
particl
pneumocyt
ident
confirm
sarscov
immunogold
label
electron
microscopi
report
first
describ
cellular
local
sarscov
human
lung
tissu
use
combin
immunohistochemistri
doublestain
immunohistochemistri
situ
hybrid
electron
microscopi
immunogold
label
see
front
matter
immunohistochem
situ
hybrid
ultrastructur
local
sarsassoci
coronaviru
lung
fatal
case
sever
acut
respiratori
syndrom
taiwan
electron
microscopi
techniqu
repres
valuabl
laboratori
diagnost
modal
provid
insight
pathogenesi
emerg
infect
elsevi
inc
right
reserv
sever
acut
respiratori
syndrom
sar
emerg
respiratori
viral
diseas
first
report
asia
februari
quickli
spread
mani
countri
north
south
america
europ
asia
decemb
global
epidem
result
report
probabl
case
fatal
variou
report
describ
diffus
alveolar
damag
main
histopatholog
find
patient
sar
sarsassoci
coronaviru
sarscov
demonstr
human
experiment
anim
tissu
immunohistochem
situ
hybrid
ish
assay
coronaviruslik
particl
detect
electron
microscopi
em
cell
bronchoalveolar
lavag
specimen
pneumocyt
postmortem
lung
sampl
coronaviru
particl
may
confus
morpholog
nonvir
cellular
compon
specif
techniqu
immunogold
label
em
iem
need
definit
character
sarscov
particl
describ
use
immunohistochemistri
ihc
ish
em
iem
patholog
diagnosi
sar
cellular
local
sarscov
also
discuss
use
techniqu
investig
pathogenesi
emerg
infect
male
patient
sought
medic
treatment
emerg
servic
nation
taiwan
univers
hospit
ntuh
taipei
taiwan
april
recurr
dyspnea
orthopnea
past
medic
histori
includ
year
type
diabet
mellitu
myocardi
infarct
year
earlier
recent
admiss
ntuh
due
acut
coronari
syndrom
congest
heart
failur
arriv
emerg
servic
patient
afebril
initi
physic
examin
reveal
temperatur
heart
rate
beat
per
minut
respir
rate
chest
xray
show
mild
pulmonari
congest
temperatur
elev
hour
later
urinalysi
show
white
blood
cell
presumpt
diagnosi
urinari
tract
infect
congest
heart
failur
made
patient
treat
antibiot
diuret
intraven
nitroglycerin
patient
admit
cardiolog
ward
day
later
becam
increasingli
dyspneic
nonproduct
cough
persist
lowgrad
fever
serial
chest
xray
show
progress
lung
infiltr
detail
histori
reveal
patient
visit
taipei
hope
citi
hospit
april
hospit
associ
larg
nosocomi
outbreak
sar
late
april
patient
immedi
isol
probabl
sar
case
throat
nasopharyng
swab
posit
sarscov
viral
isol
polymeras
chain
reaction
pcr
assay
transfer
intens
care
unit
april
sudden
onset
mental
statu
chang
hypotens
melena
patient
subsequ
develop
ventricular
fibril
die
day
later
lung
tissu
obtain
limit
autopsi
fix
buffer
formalin
paraffin
embed
tissu
section
stain
routin
hematoxylin
eosin
histopatholog
evalu
immunohistochemistri
perform
previous
describ
use
colorimetr
indirect
immunoalkalin
phosphatas
method
hyperimmun
mous
antisarscov
ascit
fluid
neg
control
includ
vero
cell
infect
human
coronaviru
vero
cell
infect
human
coronaviru
noninfect
vero
cell
tissu
nonsar
case
normal
mous
antiserum
use
neg
control
antibodi
doublestain
ihc
perform
use
peroxidas
polym
dako
carpinteria
ca
label
antibodi
cytokeratin
surfact
dako
follow
mous
antisarscov
antibodi
label
immunoalkalin
phosphatas
polym
colorimetr
ish
perform
previous
describ
briefli
negativesens
digoxinlabel
riboprob
gener
pcr
product
amplifi
nucleocapsid
n
base
length
polymeras
pol
base
length
region
sarscov
genom
tail
promot
tissu
section
incub
pool
n
pol
probe
specimen
em
excis
paraffinembed
block
lung
area
correspond
posit
ihc
ish
result
tissu
deparaffin
xylen
embed
em
previous
describ
immunogold
label
assay
use
mous
antisarscov
antibodi
ihc
experi
antibodi
detect
use
goat
antimous
conjug
colloid
gold
lung
show
featur
characterist
prolif
phase
diffus
alveolar
damag
desquam
epitheli
cell
fibrin
deposit
alveolar
space
hyperplasia
type
ii
pneumocyt
increas
mononuclear
inflammatori
cell
infiltr
interstitium
fig
multinucl
syncyti
cell
observ
sarscov
antigen
abund
distribut
multifoc
lung
viral
antigen
seen
predominantli
cytoplasm
pneumocyt
fig
c
fig
histopatholog
lung
sar
patient
show
diffus
alveolar
damag
character
desquam
epitheli
cell
fibrin
deposit
alveolar
space
hyperplasia
type
ii
pneumocyt
increas
mononuclear
infiltr
interstitium
hematoxylin
eosin
stain
b
c
sarscov
antigen
pneumocyt
immunoalkalin
phosphatas
naphthol
fastr
substrat
hematoxylin
counterstain
e
sarscov
nucleic
acid
pneumocyt
ish
naphthol
fastr
substrat
hematoxylin
counterstain
f
h
sarscovinfect
interstiti
cell
viral
nucleocapsid
inclus
bodi
arrow
virion
cellular
vesicl
arrowhead
g
sarscov
antigen
detect
within
cytoplasm
inclus
immunogold
label
colloid
gold
bar
size
indic
micromet
nanomet
occasion
macrophag
associ
intraalveolar
necrot
debri
doubl
stain
reveal
infect
cell
pneumocyt
colabel
cytokeratin
fig
predominantli
type
ii
pneumocyt
colabel
surfact
fig
less
frequent
macrophag
colabel
fig
neg
control
show
stain
ihc
antisarscov
antibodi
normal
mous
antiserum
show
stain
sarscovinfect
vero
cell
lung
tissu
case
viral
nucleic
acid
detect
ish
distribut
similar
identifi
use
ihc
mainli
pneumocyt
macrophag
fig
e
electron
microscopi
examin
lung
tissu
select
area
abund
ihc
stain
show
numer
viral
particl
nucleocapsid
inclus
typic
famili
coronavirida
virion
predominantli
seen
cytoplasm
vesicl
fig
h
along
cell
membran
pneumocyt
attach
basement
membran
free
alveolar
space
phagosom
macrophag
fig
inset
associ
fibrin
alveolar
space
fig
infect
cell
also
promin
coronaviru
nucleocapsid
inclus
fig
h
viral
natur
observ
particl
cytoplasm
inclus
confirm
iem
label
fig
report
describ
local
sarscov
variou
cellular
extracellular
locat
lung
patient
die
sar
previou
studi
demonstr
cellular
tropism
sarscov
tissu
patient
use
ish
em
immunohistochem
also
use
local
viral
antigen
human
tissu
tissu
anim
experiment
infect
sarscov
knowledg
first
report
local
sarscov
human
tissu
use
iem
doublestain
ihc
earlier
studi
human
case
abl
demonstr
viral
antigen
lung
ihc
like
explan
tissu
sampl
patient
studi
obtain
clinic
cours
last
longer
day
recent
report
chong
et
al
similar
observ
document
inabl
ish
detect
viral
nucleic
acid
patient
die
beyond
day
patient
case
report
die
day
onset
symptom
coronaviru
antigen
rna
could
detect
ihc
ish
electron
microscopi
also
identifi
viral
particl
lung
tissu
viral
natur
particl
confirm
iem
case
need
character
tempor
relationship
durat
ill
viral
clearanc
human
lung
tissu
develop
specif
ihc
ish
iem
identifi
sarscov
formalinfix
paraffinembed
sampl
also
allow
us
assess
cellular
tropism
sarscov
infect
human
lung
tissu
sarscov
antigen
local
primarili
cytoplasm
type
ii
pneumocyt
occasion
alveolar
macrophag
type
ii
pneumocyt
known
secret
pulmonari
surfact
reduc
surfac
tension
preserv
integr
alveolar
space
cell
also
play
import
role
tissu
restitut
lung
damag
also
mount
evid
support
contribut
develop
acut
inflammatori
lung
injuri
exposur
biolog
chemic
agent
type
ii
pneumocyt
directli
infect
bacteria
virus
modul
correspond
pathogenesi
organ
addit
studi
need
defin
role
type
ii
pneumocyt
alveolar
macrophag
sarscov
infect
haagman
et
al
show
extens
sarscov
antigen
express
experiment
infect
cynomolgu
macaqu
day
postinfect
antigen
mainli
alveolar
line
epitheli
cell
morpholog
characterist
type
pneumocyt
suggest
type
pneumocyt
primari
target
sarscov
infect
earli
diseas
recent
studi
use
nonhuman
primat
model
examin
lung
tissu
day
postinfect
monkey
demonstr
type
pneumocyt
main
type
cell
involv
earli
stage
wherea
type
ii
pneumocyt
involv
type
pneumocyt
normal
repres
alveolar
epitheli
cell
volum
easili
damag
pulmonari
infect
type
injuri
type
ii
pneumocyt
resist
damag
featur
import
repair
process
cell
produc
surfact
prolifer
differenti
type
cell
lung
damag
collect
data
indic
sarscov
infect
type
ii
pneumocyt
clearanc
local
viru
may
depend
stage
ill
well
individu
immunolog
respons
target
cell
sarscov
infect
bronchiolar
epitheli
cell
may
also
signific
role
viru
replic
transmiss
emerg
sarscov
pose
major
threat
global
health
specif
etiolog
diagnosi
particularli
import
sarscov
diseas
outbreak
impact
hospit
infect
control
public
health
measur
clinic
featur
sarscov
infect
similar
mani
respiratori
infect
definit
diagnosi
made
laboratori
confirm
laboratori
assay
current
use
sar
diagnosi
includ
viru
isol
pcr
serolog
pathologybas
method
ihc
ish
em
iem
offer
advantag
interpret
test
result
within
morpholog
context
also
use
diagnosi
appropri
tissu
specimen
avail
despit
limit
tissu
sampl
singl
case
report
abl
success
use
specif
ihc
ish
iem
method
sarscov
detect
human
lung
tissu
method
help
enhanc
patholog
diagnosi
understand
pathogenesi
sarscov
infect
